USNA (Usana Health Sciences) Stock Based Compensation: $14.4 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

USNA Usana Health Sciences Inc USNA
66 GF Score
Price $22.12
GF Value $41.43
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Usana Health Sciences Stock Based Compensation?

Usana Health Sciences USNA -1.25% 66 Stock Based Compensation is $14.4 Mil as of Mar. 2026. GuruFocus rates USNA with a GF Score™ of 66/100 and a GF Value™ of $41.43 (Possible Value Trap). The stock has 7 warning signs investors should review.

Usana Health Sciences's Stock Based Compensation for the three months ended in Mar. 2026 was $3.5 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 was $14.4 Mil.

Usana Health Sciences Stock Based Compensation Related Terms

Usana Health Sciences Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Usana Health Sciences's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Usana Health Sciences Stock Based Compensation Chart

Usana Health Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.30 13.33 14.60 14.56 13.83

Usana Health Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.88 3.62 3.58 3.75 3.45
USNA
66GF Score
Usana Health Sciences Inc USNA
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Usana Health Sciences Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.4 Mil.

What does a Stock Based Compensation of $14.4 Mil mean?
Usana Health Sciences (USNA) has a Stock Based Compensation of $14.4 Mil as of Mar. 2026. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Usana Health Sciences and its competitors.
Is Usana Health Sciences' Stock Based Compensation too high?
Usana Health Sciences' current Stock Based Compensation is $14.4 Mil. Overall, Usana Health Sciences has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Usana Health Sciences' Stock Based Compensation compare to NATR and ENHA?
Usana Health Sciences' Stock Based Compensation of $14.4 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Consumer Packaged Goods company?
A good Stock Based Compensation depends on the Consumer Packaged Goods industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Usana Health Sciences and its competitors. Usana Health Sciences's current Stock Based Compensation is $14.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Usana Health Sciences stock overvalued right now?
Based on GuruFocus' analysis, Usana Health Sciences (USNA) is currently considered Possible Value Trap. The stock's GF Value™ is $41.43, compared to a current price of $22.12 — trading 46.6% below its estimated fair value. The current Stock Based Compensation is $14.4 Mil. Usana Health Sciences' overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Usana Health Sciences (USNA), the current Stock Based Compensation is $14.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Usana Health Sciences (USNA) Overvalued in 2026?

Based on GuruFocus' analysis, Usana Health Sciences stock appears to be undervalued. The current stock price of $22.12 is trading 46.6% below its estimated GF Value™ of $41.43. GuruFocus considers Usana Health Sciences to be Possible Value Trap.

Key valuation signals for USNA:

  • Stock Based Compensation: $14.4 Mil
  • GF Value™: $41.43 vs. price of $22.12 (46.6% below fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the USNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Usana Health Sciences Business Description

Other Exchanges USJ:Germany
Address 3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).
66GF Score

Get the complete analysis for USNA

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$22.12
Price
$41.43
GF Value